Indian Army
Uttar Pradesh | Agra |
- Download
Time left to bid
13
Days17
Hours5
MinutesTender Roadmap
Publish Date
26 Jul 2025
Tender is published for seller Participation.
Bid Submission End Date
16 Aug 2025
Last day to participate Tender on Gem platform.
Evaluation Date
16 Aug 2025
Technical committe will evaluate Bid and Open Results.
Earnest Amount | |||||||||||||||||||||||||||||
0 | |||||||||||||||||||||||||||||
Tender Amount | |||||||||||||||||||||||||||||
0.58 Cr | |||||||||||||||||||||||||||||
Department | |||||||||||||||||||||||||||||
Department Of Military Affairs | |||||||||||||||||||||||||||||
Item Category | |||||||||||||||||||||||||||||
5mg Tab Insulin Highly Purified Isophane Human NPH 100 IU Per ml 10 ml vial Pioglitazone 15mg tab Tab Thyroxine Sodium 12.5 mcg Estriol 1 mg per gm cream tube of 15 mg Tab Alpha Keto analogue of aminoacids Cap Ubidecarenone 180 mg Calcium Phosphate 0.24 mg Per 5 ml Syp Protein Supplement for Predialysis renal failure 400 gm jar Tacrolimus 0.5mg Cap Sevelamer Carbonate Sachet 800 mg Timolol Maleate 0.5 Percent bott of 5 ml Ciprofloxacin HCl 0.3 Percent Tube of 5 gm Ciprofloxacin HCl 0.3 Percent Plus Dexamethasone 0.1 Percent bott of 5ml Cyclosporine eye drop 0.05 Percent bott of 5 ml Ketorolac Tromethamine 0.4 Percent Eye drops bott of 5 ml Loteprednol Etabonate 0.5 Percent bott of 5 ml Hydroxy Methyl Cellulose 2 Percent 2 ml Inj Natamycin 3 Percent eye drops in 3 ml bott Ofloxacin 0.3 Percent bott of 5 ml Pilocarpine Nitrate eye solution 2 Percent bott of 5 ml Prednisolone acetate 1 Percent w Per v bott of 5 ml Cream Luliconazole tube of 15 gm Timolol Maleate eye drops 0.5 Percent bott of 5 ml Atropine sulphate 1 Percent w Per v bott of 3 ml Bimatoprost 0.03 Percent bott of 3ml Dorzolamide 2 Percent Plus Timolol 0.5 Percent bott of 5 ml Olopatadine Hydrochloride 0.1 Percent Ophthalmic Soln bott of 5 ml Moxifloxacin HCl 0.5 Percent Plus Dexamethasone 0.1 Percent ophthalmic Soln bott of 5ml Cinnarizine 25 mg Tab Prochlorperazine Maleate 5mg Tab Chloramphenicol 5 Percent w Per v Clotrimazole 1 Percent w Per v Betamethasone 0.25 Percent w Per v Lignocaine HCl 2 Percent w Per v in bott of 5 ml Syp Baclofen 1 mg Per ml Bottle of 5ml Iron drops Paediatric. | |||||||||||||||||||||||||||||
Purchaser Address | |||||||||||||||||||||||||||||
AGRA | |||||||||||||||||||||||||||||
Work Description | |||||||||||||||||||||||||||||
611 ECHS IFA Gen Med GeM 13 FY 25 26;1402792;5mg Tab Insulin Highly Purified Isophane Human NPH 100 IU Per ml 10 ml vial Pioglitazone 15mg tab Tab Thyroxine Sodium 12.5 mcg Estriol 1 mg per gm cream tube of 15 mg Tab Alpha Keto analogue of aminoacids Cap Ubidecarenone 180 mg Calcium Phosphate 0.24 mg Per 5 ml Syp Protein Supplement for Predialysis renal failure 400 gm jar Tacrolimus 0.5mg Cap Sevelamer Carbonate Sachet 800 mg Timolol Maleate 0.5 Percent bott of 5 ml Ciprofloxacin HCl 0.3 Percent Tube of 5 gm Ciprofloxacin HCl 0.3 Percent Plus Dexamethasone 0.1 Percent bott of 5ml Cyclosporine eye drop 0.05 Percent bott of 5 ml Ketorolac Tromethamine 0.4 Percent Eye drops bott of 5 ml Loteprednol Etabonate 0.5 Percent bott of 5 ml Hydroxy Methyl Cellulose 2 Percent 2 ml Inj Natamycin 3 Percent eye drops in 3 ml bott Ofloxacin 0.3 Percent bott of 5 ml Pilocarpine Nitrate eye solution 2 Percent bott of 5 ml Prednisolone acetate 1 Percent w Per v bott of 5 ml Cream Luliconazole tube of 15 gm Timolol Maleate eye drops 0.5 Percent bott of 5 ml Atropine sulphate 1 Percent w Per v bott of 3 ml Bimatoprost 0.03 Percent bott of 3ml Dorzolamide 2 Percent Plus Timolol 0.5 Percent bott of 5 ml Olopatadine Hydrochloride 0.1 Percent Ophthalmic Soln bott of 5 ml Moxifloxacin HCl 0.5 Percent Plus Dexamethasone 0.1 Percent ophthalmic Soln bott of 5ml Cinnarizine 25 mg Tab Prochlorperazine Maleate 5mg Tab Chloramphenicol 5 Percent w Per v Clotrimazole 1 Percent w Per v Betamethasone 0.25 Percent w Per v Lignocaine HCl 2 Percent w Per v in bott of 5 ml Syp Baclofen 1 mg Per ml Bottle of 5ml Iron drops Paediatric.
|
|||||||||||||||||||||||||||||
Eligibility | |||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
My Evaluation Notes | |||||||||||||||||||||||||||||
|